MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from
underwritten public offering
$15,000K
Proceeds from credit
facility
$1,000K
Net cash provided by
financing activities
$9,035K
Canceled cashflow
$6,965K
Net change in cash
and cash...
-$5,736K
Canceled cashflow
$9,035K
Redemption of short-term
investments
$1,986K
Stock-based compensation
expense
$1,022K
Accounts payable and
accrued expenses
$489K
Other assets
-$146K
Depreciation and
amortization
$96K
Noncash interest
expense
$17K
Payment to investors
pursuant to letter...
$4,502K
Offering costs for sale of
common stock
$1,363K
Repayment of credit
facility
$1,100K
Net cash (used in)
provided by investing...
-$8,533K
Canceled cashflow
$1,986K
Net cash used in
operating activities
-$6,238K
Canceled cashflow
$1,770K
Purchase of short-term
investments
$9,701K
Purchases of property and
equipment
$818K
Net loss
-$6,946K
Grant receivable
$1,028K
Operating lease
right-of-use asset...
-$40K
Back
Back
Cash Flow
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)
source: myfinsight.com